A dual-action GLP-1/GIP program supervised by a licensed provider.
A dual-action GLP-1/GIP program supervised by a licensed provider.
Your provider reviews your health history, medications, and goals to confirm candidacy.
Labs may be requested to establish a safe starting point.
Treatment begins at a low dose selected by your provider.
Regular visits track your response and any side effects.
Your dose is adjusted gradually based on tolerance and progress.
Acts on two hormone receptors involved in appetite and blood sugar regulation.
Starting dose and increases are set and monitored by your provider.
A slow dose increase is designed to help limit gastrointestinal side effects.
REGULAR CHECK-INS Scheduled follow-up appointments track your progress.
Your protocol is adjusted to your response, not a fixed schedule.
Nutrition and activity guidance are part of the program.
For patients whose response to single-pathway medications has been limited, tirzepatide’s dual mechanism is one option your provider may consider as part of an individualized plan.
Tirzepatide carries the same thyroid-related contraindications as other medications in this class and is not used with a personal or family history of medullary thyroid carcinoma or MEN 2, nor during pregnancy. Gastrointestinal side effects such as nausea and diarrhea are the most commonly reported; your provider reviews the complete risk profile before you begin.
Regular follow-up allows your provider to track your progress, manage side effects, and adjust your dose over time.
Your provider also addresses nutrition and activity, which support results beyond the medication itself.
Your plan is set and adjusted by your provider based on your response.
Scheduled visits keep your care team involved throughout treatment.
Nutrition and lifestyle guidance are included as part of your plan.
Tirzepatide is a prescription medication that acts on both GLP-1 and GIP receptors to influence appetite and blood sugar regulation. It is provided only after a provider evaluation.
Tirzepatide acts on two hormone receptors rather than one. Your provider will help determine which option, if either, fits your health history and goals.
Gastrointestinal effects such as nausea, diarrhea, and reduced appetite are most commonly reported, particularly during dose increases. Your provider will discuss the full risk profile with you.
Yes. Regular follow-up is part of the program so your provider can monitor your progress and adjust your plan as needed.
Disclaimer: The information on this website is for general informational purposes only and is not legal, tax, accounting, insurance, or medical advice. Ma Belle Wellness and Aesthetics provides healthcare business consulting, medical director placement, company formation coordination, operational consulting, documentation preparation, and compliance support. Ma Belle Wellness and Aesthetics is not a law firm, accounting firm, insurance agency, or healthcare provider, and does not provide legal representation, tax advice, accounting services, insurance advice, or direct patient care.
Medical Directors introduced through Ma Belle Wellness and Aesthetics are independent licensed professionals who exercise their own independent medical judgment. Ma Belle Wellness and Aesthetics does not direct, supervise, or control any Medical Director’s clinical decisions. Nothing on this website creates an attorney-client, accountant-client, or physician-patient relationship. Clients are solely responsible for obtaining independent legal, tax, accounting, insurance, and regulatory advice. Read the full disclaimer.
© 2026 – Ma Belle Wellness & Aesthetics, All Rights Reserved
